The clinical features, treatment and outcomes of 33 children from Northwestern China with Anti-N-methyl-D-aspartate receptor encephalitis

References

• Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091–1098.
   PubMed Web of Science ®Google Scholar
• Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11–18.
   PubMed Web of Science ®Google Scholar
• Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63–74.
   PubMed Web of Science ®Google Scholar
• Brenton JN, Kim J, Schwartz RH. Approach to the Management of Pediatric-Onset Anti-N-Methyl-d-Aspartate (Anti-NMDA) Receptor Encephalitis. J Child Neurol. 2016;31(9):1150–1155.
   PubMed Web of Science ®Google Scholar
• Byrne S, Walsh C, Hacohen Y, et al. Earlier treatment of nmdar antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol NeuroInflammation. 2015;2(4):1–3.
   Web of Science ®Google Scholar
• Rutatangwa A, Mittal N, Francisco C, et al. Autoimmune Encephalitis in Children: a Case Series at a Tertiary Care Center. J Child Neurol. 2020;35(9):591–599.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ji T, Chen Q, et al. Pediatric autoimmune encephalitis: case series from two Chinese tertiary pediatric neurology centers. Front Neurol. 2019;10:1–9.
   PubMed Web of Science ®Google Scholar
• Byrne S, Mccoy B, Lynch B, et al. Does early treatment improve outcomes in N-methyl-d-aspartate receptor encephalitis? Dev Med Child Neurol. 2014;56(8):794–796.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang W, Yin J, et al. Anti-N-methyl-D-aspartate receptor encephalitis in children of Central South China: clinical features, treatment, influencing factors, and outcomes. J Neuroimmunol. 2017;312:59–65.
   PubMed Web of Science ®Google Scholar
• Zekeridou A, Karantoni E, Viaccoz A, et al. Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis. J Neurol. 2015;262(8):1859–1866.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li W, Zhou S, et al. Clinical features, treatment, and outcomes among Chinese children with anti-methyl-d-aspartate receptor (Anti-NMDAR) encephalitis. Front Neurol. 2019;10:1–9.
   PubMed Web of Science ®Google Scholar
• Norioka R, Kumada S, Tobisawa S, et al. Clinical characteristics of children and adults with anti-N-methyl-D-aspartate receptor encephalitis. Clin Neurol Neurosurg. 2020;196:106015.
   PubMed Web of Science ®Google Scholar
• Lim JA, Lee ST, Jung KH, et al. Anti-N-methyl-D-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome. J Clin Neurol. 2014;10(2):157–161.
   PubMed Web of Science ®Google Scholar
• Wang W, Li JM, Hu FY, et al. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China. Eur J Neurol. 2016;23(3):621–629.
   PubMed Web of Science ®Google Scholar
• Haberlandt E, Ensslen M, Gruber-Sedlmayr U, et al. Epileptic phenotypes, electroclinical features and clinical characteristics in 17 children with anti-NMDAR encephalitis. Eur J Paediatr Neurol. 2017;21(3):457–464.
   PubMed Web of Science ®Google Scholar
• Sartori S, Nosadini M, Cesaroni E, et al. Paediatric anti-N-methyl-d-aspartate receptor encephalitis: the first Italian multicenter case series. Eur J Paediatr Neurol. 2015;19(4):453–463.
   PubMed Web of Science ®Google Scholar
• Dale RC, Gorman MP, Lim M. Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges. Curr Opin Neurol. 2017;30(3):334–344.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu G, Jiang M, et al. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-d-aspartate Receptor Encephalitis Patients. Neurocrit Care. 2018;29(2):264–272.
   PubMed Web of Science ®Google Scholar
• Da Silva-Júnior FP, Castro LHM, Andrade JQ, et al. Serial and prolonged EEG monitoring in anti-N-Methyl-d-Aspartate receptor encephalitis. Clin Neurophysiol. 2014;125(8):1541–1544.
   PubMed Web of Science ®Google Scholar
• Huang Q, Wu Y, Qin R, et al. Clinical characteristics and outcomes between children and adults with anti-N-Methyl-d-Aspartate receptor encephalitis. J Neurol. 2016;263(12):2446–2455.
   PubMed Web of Science ®Google Scholar
• Huang X, Fan C, Wu J, et al. Clinical analysis on anti-N-methyl-D-aspartate receptor encephalitis cases: chinese experience. Int J Clin Exp Med. 2015;8:18927–18935.
   PubMed Web of Science ®Google Scholar
• Salvucci A, Devine IM, Hammond D, et al. Pediatric anti-NMDA (N-methyl D-Aspartate) receptor encephalitis. Pediatr Neurol. 2014;50(5):507–510.
   PubMed Web of Science ®Google Scholar
• Sai Y, Zhang X, Feng M, et al. Clinical diagnosis and treatment of pediatric anti-n-methyl-d-aspartate receptor encephalitis: a single center retrospective study. Exp Ther Med. 2018;16:1442–1448.
   PubMed Web of Science ®Google Scholar
• Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–165.
   PubMed Web of Science ®Google Scholar
• Xu X, Lu Q, Huang Y, et al. Anti-NMDAR encephalitis: a single-center, longitudinal study in China. Neurol Neuroimmunol Neuroinflammation. 2020;7. DOI:https://doi.org/10.1212/NXI.0000000000000633.
   Google Scholar
• Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13(2):167–177.
   PubMed Web of Science ®Google Scholar
• Dou X, Li D, Wu Y, et al. Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis. Front Neurol. 2020;11:1–9.
   PubMed Web of Science ®Google Scholar